| Bioactivity | HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as 188Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research[1]. |
| Invitro | 在核医学中，将放射性同位素与HYNIC-PSMA配体结合，可实现对前列腺特异性膜抗原（PSMA）的非侵入性成像。还可以通过靶向前列腺癌细胞上过表达的PSMA来定位和显像肿瘤病灶[1]。 |
| Name | HYNIC-PSMA |
| CAS | 2213408-17-2 |
| Sequence | Glu-Urea-Lys(Ahx-HYNIC) |
| Shortening | Glu-Urea-Lys(Ahx-HYNIC) |
| Formula | C24H37N7O9 |
| Molar Mass | 567.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hadisi M, et al. Preclinical evaluation of 188 Re-HYNIC-PSMA as a novel therapeutic agent[J]. Journal of Radioanalytical and Nuclear Chemistry, 2022, 331(2): 841-849. |
HYNIC-PSMA
CAS: 2213408-17-2 F: C24H37N7O9 W: 567.59
HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.